Halichondrin B Analog Synthesis via Segmented Intermediates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing halichondrin B analogs, such as eribulin, face challenges in obtaining new intermediates that are essential for improving the efficiency and stereoselectivity of the synthesis process.
Innovation Solution
The development of specific compounds with formulas (I), (II), and (III), which include various functional groups and protecting groups, allows for the synthesis of ER-804028 and other halichondrin B analogs through Nozaki-Hiyama-Kishi coupling, Vasella fragmentation, and intramolecular Williamson etherification, enhancing stereoselectivity and stability of intermediates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If current synthesis methods are used, then existing intermediates can be obtained, but stereoselectivity at specific carbon positions is insufficient and synthesis complexity increases
Solution Approach 1:
The synthesis is divided into modular stages using distinct intermediate compounds (formula I, II, III) that can be independently prepared and characterized. Each intermediate serves as a building block with specific functional groups that facilitate controlled stereoselective transformations at critical carbon positions without requiring complex multi-step sequences.
Solution Approach 2:
The patent introduces specific intermediate compounds with defined structures (formulas I, II, III) that act as mediators in the synthesis pathway. These intermediates contain strategic functional groups and protecting groups that enable stereoselective reactions at specific carbon positions, simplifying the overall synthesis while improving stereochemical control.
2Productivity
If existing synthesis pathways are used, then halichondrin B analogs can be produced, but intermediate stability is insufficient leading to lower yields
Solution Approach 1:
The intermediate compounds are designed with pre-installed protecting groups and functional group configurations that stabilize them during storage and subsequent reactions. The protecting groups prevent unwanted side reactions and decomposition, maintaining intermediate stability throughout the synthesis process and improving overall yield.
Solution Approach 2:
The patent modifies molecular parameters of the intermediates by introducing specific protecting groups and functional group arrangements (formulas I, II, III) that enhance stability. These structural modifications change the chemical properties of intermediates to be more resistant to degradation while maintaining reactivity toward the desired transformations.
Data Source
AI summary
In general, the invention features compounds useful for the synthesis of analogs of halichondrin B, such as eribulin or pharmaceutically acceptable salts thereof, e.g., eribulin mesylate. Exemplary compounds are of formula (I), (II), or (III):